Company intelligence / Profile preview

Beroni Pharmaceutical (Guangdong) Co., Ltd.

Zhuhai, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Beroni Group (through its drug development arm including Beroni Pharmaceutical (Guangdong)) has an oncology and immunotherapy pipeline and is advancing an anti-cancer molecular targeted drug into Phase 2 clinical trials; detailed molecule-level clinical data are not publicly disclosed.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Small moleculeCell therapyVaccineRNA therapyDNA vaccine
Industry: Biotech

Partnerships

Collaboration with international research institutions for immune cell therapies and new cancer drug development (at Beroni Group level; Guangdong entity participates as a core R&D arm).

Beyond the preview

Go deeper on Beroni Pharmaceutical (Guangdong) Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beroni Pharmaceutical (Guangdong) Co., Ltd..

Explore the full profile